Polina Weitzenfeld

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

Gali Soria, Maya Ofri-Shahak, Neora Yaal‐Hahoshen et al. · BMC Cancer · 2011 · 280 citations · Full text

Medicine, Cancer Biology, Oncology +17

Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity

Itziar Ibarlucea-Benitez, Polina Weitzenfeld, Patrick Smith et al. · Proceedings of the National Academy of Sciences · 2021 · 176 citations · Full text

Medicine, Immunology, Oncology +17

Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways

Polina Weitzenfeld, Stylianos Bournazos, Jeffrey V. Ravetch · Journal of Clinical Investigation · 2019 · 60 citations · Full text

Life Sciences, Immunology, Oncology +17

Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors

Polina Weitzenfeld, Olga Kossover, Cindy Körner et al. · Journal of Leukocyte Biology · 2016 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

Epidermal Growth Factor and Estrogen Act by Independent Pathways to Additively Promote the Release of the Angiogenic Chemokine CXCL8 by Breast Tumor Cells

Karin Haim, Polina Weitzenfeld, Tsipi Meshel et al. · Neoplasia · 2011 · 33 citations · Full text

Medicine, Cell Biology, Oncology +17